Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Trends in Prevalence of Advanced HIV Disease at Antiretroviral Therapy Enrollment - 10 Countries, 2004-2015.

Auld AF, Shiraishi RW, Oboho I, Ross C, Bateganya M, Pelletier V, Dee J, Francois K, Duval N, Antoine M, Delcher C, Desforges G, Griswold M, Domercant JW, Joseph N, Deyde V, Desir Y, Van Onacker JD, Robin E, Chun H, Zulu I, Pathmanathan I, Dokubo EK, Lloyd S, Pati R, Kaplan J, Raizes E, Spira T, Mitruka K, Couto A, Gudo ES, Mbofana F, Briggs M, Alfredo C, Xavier C, Vergara A, Hamunime N, Agolory S, Mutandi G, Shoopala NN, Sawadogo S, Baughman AL, Bashorun A, Dalhatu I, Swaminathan M, Onotu D, Odafe S, Abiri OO, Debem HH, Tomlinson H, Okello V, Preko P, Ao T, Ryan C, Bicego G, Ehrenkranz P, Kamiru H, Nuwagaba-Biribonwoha H, Kwesigabo G, Ramadhani AA, Ng'wangu K, Swai P, Mfaume M, Gongo R, Carpenter D, Mastro TD, Hamilton C, Denison J, Wabwire-Mangen F, Koole O, Torpey K, Williams SG, Colebunders R, Kalamya JN, Namale A, Adler MR, Mugisa B, Gupta S, Tsui S, van Praag E, Nguyen DB, Lyss S, Le Y, Abdul-Quader AS, Do NT, Mulenga M, Hachizovu S, Mugurungi O, Barr BAT, Gonese E, Mutasa-Apollo T, Balachandra S, Behel S, Bingham T, Mackellar D, Lowrance D, Ellerbrock TV.

MMWR Morb Mortal Wkly Rep. 2017 Jun 2;66(21):558-563. doi: 10.15585/mmwr.mm6621a3.

2.

Combatting Global Infectious Diseases: A Network Effect of Specimen Referral Systems.

Fonjungo PN, Alemnji GA, Kebede Y, Opio A, Mwangi C, Spira TJ, Beard RS, Nkengasong JN.

Clin Infect Dis. 2017 Feb 13. doi: 10.1093/cid/ciw817. [Epub ahead of print]

PMID:
28200031
3.

Lower Levels of Antiretroviral Therapy Enrollment Among Men with HIV Compared with Women - 12 Countries, 2002-2013.

Auld AF, Shiraishi RW, Mbofana F, Couto A, Fetogang EB, El-Halabi S, Lebelonyane R, Pilatwe PT, Hamunime N, Okello V, Mutasa-Apollo T, Mugurungi O, Murungu J, Dzangare J, Kwesigabo G, Wabwire-Mangen F, Mulenga M, Hachizovu S, Ettiegne-Traore V, Mohamed F; MSAE, Bashorun A, Nhan do T, Hai NH, Quang TH, Van Onacker JD, Francois K, Robin EG, Desforges G, Farahani M, Kamiru H, Nuwagaba-Biribonwoha H, Ehrenkranz P, Denison JA, Koole O, Tsui S, Torpey K, Mukadi YD, van Praag E, Menten J, Mastro TD, Hamilton CD, Abiri OO, Griswold M, Pierre E, Xavier C, Alfredo C, Jobarteh K, Letebele M, Agolory S, Baughman AL, Mutandi G, Preko P, Ryan C, Ao T, Gonese E, Herman-Roloff A, Ekra KA, Kouakou JS, Odafe S, Onotu D, Dalhatu I, Debem HH, Nguyen DB, Yen le N, Abdul-Quader AS, Pelletier V, Williams SG, Behel S, Bicego G, Swaminathan M, Dokubo EK, Adjorlolo-Johnson G, Marlink R, Lowrance D, Spira T, Colebunders R, Bangsberg D, Zee A, Kaplan J, Ellerbrock TV.

MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1281-6. doi: 10.15585/mmwr.mm6446a2.

4.

Postexposure Prophylaxis Against Human Immunodeficiency Virus (HIV): New Guidelines From the WHO: A Perspective.

Kaplan JE, Dominguez K, Jobarteh K, Spira TJ.

Clin Infect Dis. 2015 Jun 1;60 Suppl 3:S196-9. doi: 10.1093/cid/civ087. No abstract available.

PMID:
25972504
5.

Temporal Trends in Patient Characteristics and Outcomes Among Children Enrolled in Mozambique's National Antiretroviral Therapy Program.

Auld AF, Alfredo C, Macassa E, Jobarteh K, Shiraishi RW, Rivadeneira ED, Houston J, Spira TJ, Ellerbrock TV, Vaz P.

Pediatr Infect Dis J. 2015 Aug;34(8):e191-9. doi: 10.1097/INF.0000000000000741.

PMID:
25955836
6.

CD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapy.

Peeling RW, Sollis KA, Glover S, Crowe SM, Landay AL, Cheng B, Barnett D, Denny TN, Spira TJ, Stevens WS, Crowley S, Essajee S, Vitoria M, Ford N.

PLoS One. 2015 Mar 19;10(3):e0115019. doi: 10.1371/journal.pone.0115019. eCollection 2015. Review.

7.

Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults--seven African countries, 2004-2013.

Auld AF, Agolory SG, Shiraishi RW, Wabwire-Mangen F, Kwesigabo G, Mulenga M, Hachizovu S, Asadu E, Tuho MZ, Ettiegne-Traore V, Mbofana F, Okello V, Azih C, Denison JA, Tsui S, Koole O, Kamiru H, Nuwagaba-Biribonwoha H, Alfredo C, Jobarteh K, Odafe S, Onotu D, Ekra KA, Kouakou JS, Ehrenkranz P, Bicego G, Torpey K, Mukadi YD, van Praag E, Menten J, Mastro T, Dukes Hamilton C, Swaminathan M, Dokubo EK, Baughman AL, Spira T, Colebunders R, Bangsberg D, Marlink R, Zee A, Kaplan J, Ellerbrock TV.

MMWR Morb Mortal Wkly Rep. 2014 Nov 28;63(47):1097-103.

8.

Commentary on Greig et al, "Similar mortality and reduced loss to follow-up in integrated compared with vertical programs providing antiretroviral treatment in sub-Saharan Africa".

Spira TJ, Ellerbrock TV.

J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):e82-4. doi: 10.1097/QAI.0b013e31824c1985. No abstract available.

PMID:
22330609
9.

Development and characterization of a bead-based, multiplex assay for estimation of recent HIV type 1 infection.

Curtis KA, Kennedy MS, Charurat M, Nasidi A, Delaney K, Spira TJ, Owen SM.

AIDS Res Hum Retroviruses. 2012 Feb;28(2):188-97. doi: 10.1089/AID.2011.0037. Epub 2011 Jun 17.

PMID:
21585287
10.

A quality management systems approach for CD4 testing in resource-poor settings.

Westerman LE, Kohatsu L, Ortiz A, McClain B, Kaplan J, Spira T, Marston B, Jani IV, Nkengasong J, Parsons LM.

Am J Clin Pathol. 2010 Oct;134(4):556-67. doi: 10.1309/AJCPP7MCHFYLX2FM.

PMID:
20855636
11.

The WHO/PEPFAR collaboration to prepare an operations manual for HIV prevention, care, and treatment at primary health centers in high-prevalence, resource-constrained settings: defining laboratory services.

Spira T, Lindegren ML, Ferris R, Habiyambere V, Ellerbrock T.

Am J Clin Pathol. 2009 Jun;131(6):887-94. doi: 10.1309/AJCPRID8CQY5THES.

PMID:
19461098
12.

Evaluating new CD4 enumeration technologies for resource-constrained countries.

Stevens W, Gelman R, Glencross DK, Scott LE, Crowe SM, Spira T.

Nat Rev Microbiol. 2008 Nov;6(11 Suppl):S29-38. No abstract available.

PMID:
22745957
13.

A North American multilaboratory study of CD4 counts using flow cytometric panLeukogating (PLG): a NIAID-DAIDS Immunology Quality Assessment Program Study.

Denny TN, Gelman R, Bergeron M, Landay A, Lam L, Louzao R, Mandy FF, Schmitz J, Spira T, Wilkening C, Glencross DK; NIAID-DAIDS Immunology Quality Assessment Program.

Cytometry B Clin Cytom. 2008;74 Suppl 1:S52-64. doi: 10.1002/cyto.b.20417.

14.

Clinical and virological characterization of persistent human infection with simian foamy viruses.

Boneva RS, Switzer WM, Spira TJ, Bhullar VB, Shanmugam V, Cong ME, Lam L, Heneine W, Folks TM, Chapman LE.

AIDS Res Hum Retroviruses. 2007 Nov;23(11):1330-7. doi: 10.1089/aid.2007.0104.

PMID:
18184074
15.

The emergence of HIV/AIDS in the Americas and beyond.

Gilbert MT, Rambaut A, Wlasiuk G, Spira TJ, Pitchenik AE, Worobey M.

Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18566-70. Epub 2007 Oct 31.

16.

Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutations.

Johnson JA, Li JF, Wei X, Lipscomb J, Bennett D, Brant A, Cong ME, Spira T, Shafer RW, Heneine W.

PLoS One. 2007 Jul 25;2(7):e638.

17.

Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma.

Laney AS, Cannon MJ, Jaffe HW, Offermann MK, Ou CY, Radford KW, Patel MM, Spira TJ, Gunthel CJ, Pellett PE, Dollard SC.

AIDS. 2007 Jul 31;21(12):1541-5.

PMID:
17630548
18.

Prevalence of HIV in the US household population: the National Health and Nutrition Examination Surveys, 1988 to 2002.

McQuillan GM, Kruszon-Moran D, Kottiri BJ, Kamimoto LA, Lam L, Cowart MF, Hubbard M, Spira TJ.

J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):651-6.

PMID:
16652040
19.

Evaluation of a new single-parameter volumetric flow cytometer (CyFlow(green)) for enumeration of absolute CD4+ T lymphocytes in human immunodeficiency virus type 1-infected Thai patients.

Pattanapanyasat K, Lerdwana S, Noulsri E, Chaowanachan T, Wasinrapee P, Sakulploy N, Pobkeeree V, Suksripanich O, Thanprasertsuk S, Spira TJ, Tappero JW, Levine WC.

Clin Diagn Lab Immunol. 2005 Dec;12(12):1416-24.

20.

Association of CCR5 human haplogroup E with rapid HIV type 1 disease progression.

Li M, Song R, Masciotra S, Soriano V, Spira TJ, Lal RB, Yang C.

AIDS Res Hum Retroviruses. 2005 Feb;21(2):111-5.

PMID:
15725749

Supplemental Content

Loading ...
Support Center